Race for vaccine against rare Ebola strain gets $8.5m boost
•A new vaccine candidate for a rare Ebola strain has received an $8.5 million funding boost.
•The vaccine is a Bundibungyo version of the already approved Ervebo shot.
•This funding aims to accelerate the development of the vaccine against the Bundibungyo Ebola virus.
Vaccine candidate is a Bundibungyo version of the Ervebo shot, which has already been approved for Ebola Zaireالمصدر: The Telegraph | Source: The Telegraph
→A new vaccine candidate for a rare Ebola strain has received an $8.5 million funding boost.
→The vaccine is a Bundibungyo version of the already approved Ervebo shot.
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة The Telegraph. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by The Telegraph. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.
